| Oct 5 2014 |
U.S. Department of Agriculture Expands Crop Insurance under 2014 Farm Bill |
Varnum LLP |
| Oct 5 2014 |
Endo Pharmaceuticals, Inc. v. Depomed, Inc., Denying Institution of Inter Partes Review IPR2014-00651 |
Faegre Drinker |
| Oct 5 2014 |
PTAB on Analogous Art, Schott Gemtron Corp. v. SSW Holding Co., Inc. |
McDermott Will & Emery |
| Oct 4 2014 |
Patent Owners: Better Address All Obviousness Arguments Raised by Petitioner, Pharmatech Solutions, Inc. v. LifeScan Scotland Ltd. |
McDermott Will & Emery |
| Oct 3 2014 |
Africa Legal News Update - October 3, 2014 |
Mintz |
| Oct 3 2014 |
New Conservation Mandate Will Apply to Specialty Crops: Producers Must File By June 1, 2015 |
McDermott Will & Emery |
| Oct 2 2014 |
Another Hefty OSHA Whistleblower Award + Reinstatement |
Proskauer Rose LLP |
| Oct 2 2014 |
Positive Drug Tests on the Rise in U.S. Workforce |
Jackson Lewis P.C. |
| Oct 2 2014 |
Becton, Dickinson and Company v. One StockDuq Holdings, LLC: Final Written Decision IPR2013-00235 |
Faegre Drinker |
| Oct 1 2014 |
Sham-Wow! Antitrust Liability May Attach to Sham Administrative Petitions: Tyco Healthcare Group LP v. Mutual Pharm. Co., Inc. |
McDermott Will & Emery |
| Oct 1 2014 |
Silence of ANDA (Abbreviated New Drug Applications) with Respect to a Claim Limitation Does Not Constitute Infringement Ferring B.V. v. Watson Labs., Inc. |
McDermott Will & Emery |
| Oct 1 2014 |
Governance Challenges, Social Barriers, and the Upcoming U.S. Mission to Fight Ebola |
Covington & Burling LLP |
| Sep 30 2014 |
Post-Therasense IC Alive and Kicking at the Federal Circuit |
McDermott Will & Emery |
| Sep 30 2014 |
The Doctrine of Obviousness-Type Double Patenting Maintains Its Vitality |
McDermott Will & Emery |
| Sep 30 2014 |
BioMarin Pharm. Inc. v. Genzyme therapeutic Products Ltd. P’ship.: Granting Request to Submit Supplemental Information IPR2013-00534, 537 |
Faegre Drinker |
| Sep 30 2014 |
Medtronic, Inc. v. NuVasive, Inc., IPR2014-00487: Decision Denying Institution |
Faegre Drinker |
| Sep 30 2014 |
Amneal Pharmaceuticals v. Endo Pharmaceuticals, IPR2014-00360: Denying Request for Rehearing of Denial of Institution |
Faegre Drinker |
| Sep 30 2014 |
Alcohol and Tobacco Tax and Trade Bureau (TTB) Issues Expanded List of Allowable Changes to Approved Labels |
McDermott Will & Emery |
| Sep 29 2014 |
Proposed Michigan Agricultural Environmental Assurance Program (MAEAP) Rules Narrow “Right to Farm” Protection |
Varnum LLP |
| Sep 29 2014 |
House Subcommittee Questions Department of Labor’s Enforcement of “Hot Goods” Provision |
Varnum LLP |
| Sep 29 2014 |
3 Ways to Protect Our Farmers This Fall |
U.S. Department of Labor |
| Sep 28 2014 |
FDA Proposes Revisions to Food Safety Rules |
Varnum LLP |
| Sep 28 2014 |
Shire Pharmaceuticals LLC to Pay $56.5 Million to Government for Allegedly Violating the False Claims Act by Engaging In Unlawful Drug Marketing and Promotion Practices |
Tycko & Zavareei LLP |
| Sep 26 2014 |
Merck Boosts Life Sciences Industry with Sigma-Aldrich Acquisition |
McDermott Will & Emery |
| Sep 26 2014 |
Nearly 10% of Americans Have Gone to Work High [INFOGRAPHIC] |
Risk and Insurance Management Society, Inc. (RIMS) |
| Sep 25 2014 |
Recent Settlement Highlights Importance of Tracing Country of Origin When Selling Medical Devices to the U.S. Government |
Covington & Burling LLP |
| Sep 25 2014 |
NFL and NFLPA Finalize Amended Substance Abuse Policies |
Jackson Lewis P.C. |
| Sep 24 2014 |
Mounting Legal Challenges to Florida Medical Marijuana Regulations |
Bilzin Sumberg |
| Sep 23 2014 |
FDA Proposes Revisions to the Proposed Foreign Supplier Verification Rule |
Covington & Burling LLP |
| Sep 23 2014 |
Energy & Environmental Law Update -- September 22, 2014 |
Mintz |
| Sep 23 2014 |
Biomarin Pharmaceutical Inc. v. Duke University: Authorizing Opposition to Motion to Exclude IPR2013-00535 |
Faegre Drinker |
| Sep 22 2014 |
Guilty Convictions in Salmonella Trial May Signify Landmark in Criminal Food-Safety Prosecutions |
Mintz |
| Sep 22 2014 |
FDA Issues Revisions to Proposed Food Safety Rules, Reopens Comment Period for Revisions Only |
Barnes & Thornburg LLP |
| Sep 22 2014 |
White House Mobilizes Forces Against Superbug |
Covington & Burling LLP |
| Sep 22 2014 |
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 1 of a 5-Part Series |
Michael Best & Friedrich LLP |
